Editorial · 30 Aug 2021
EditorialPublished 30 Sep 2021
Hypertonic Saline Solution Shown to Inhibit Replication of SARS-CoV-2
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Research article · 2016
Effect of Nebulized 3% Hypertonic Saline on Intensive Care Unit Admission Rates of Infants with Moderate Acute Bronchiolitis
Editorial · 29 Jul 2021
Mutation and Replication of SARS-COV-2
Research article · 8 Jul 2024
Molecular Model of Inhibition of the Catalytic Fragment of Domain ExoN of Exoribonuclease of Virus SARS-CoV-2-Betacoronavirus B by Drug FS-1 Containing Molecular Iodine and Lithium and Magnesium Halides.
Research article · 16 Sep 2021
Investigating the Inhibition Effect of Portulaca Oleracea against SARS-COV-2 through Molecular Docking Simulation
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joshua Ikoni Ogaji”

